Riskpilot← Back to searchSign inGet full accessOneLab AB
ABActiveOrg 5569704264Torsgatan 13General medical practice activities · NACE 8621Est. 201450-99 employees
Revenue 2024
SEK 40,6M
+25% vs 2023
EBITDA margin
-7.4%
+78% vs 2023
Equity ratio
53.1%
Financial strength
Net profit 2024
SEK -6M
+61% vs 2023
| Revenue | SEK 40,6M | +25% |
| EBITDA | SEK -3M | +78% |
| Net profit | SEK -6M | +61% |
| Total assets | SEK 53,7M | -5% |
| Equity | SEK 28,5M | -17% |
| Employees | — | — |
Legal name
OneLab AB
Org number
5569704264
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
2 maj 2014
Share capital
SEK 183 870
Employees
50-99
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet är att bedriva företags- hälsovård samt därmed förenlig verksamhet.
Address
Torsgatan 13
Email
info@onelab.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 10 659 | 13 338 | 15 415 | 24 305 | 34 424 | 32 463 | 40 564 |
| Staff expenses | — | — | — | — | — | — | — | — | — | −35 613 |
| EBITDA | −485 | −2 069 | −2 629 | −2 880 | −7 278 | −4 867 | −15 734 | −15 109 | −13 968 | −3 020 |
| Depreciation & amort. | −0 | −0 | −0 | −4 | −4 | −25 | −101 | −1 296 | −2 302 | −3 518 |
| EBIT | −485 | −2 069 | −2 629 | −2 884 | −7 282 | −4 892 | −15 835 | −16 405 | −16 270 | −6 538 |
| Net financials | — | −3 | −5 | −1 | −10 | −3 | −1 | 27 | 748 | 546 |
| Profit before tax | −485 | −2 073 | −2 633 | −2 885 | −7 292 | −4 895 | −15 837 | −16 378 | −15 522 | −5 993 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | — |
| Net profit | −485 | −2 073 | −2 633 | −2 885 | −7 292 | −4 895 | −15 837 | −16 378 | −15 522 | −5 993 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4 459 | 12 196 | 9 762 | 7 738 | 14 347 | 14 783 | 52 137 | 70 014 | 56 519 | 53 738 |
| Equity | 3 409 | 10 796 | 8 163 | 5 351 | 10 175 | 5 279 | 26 637 | 50 257 | 34 543 | 28 550 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Short-term debt | 1 050 | 1 400 | 1 599 | 2 387 | 4 172 | 9 504 | 25 500 | 19 757 | 21 976 | 25 188 |
| Total debt | 1 050 | 1 400 | 1 599 | 2 387 | 4 172 | 9 504 | 25 500 | 19 757 | 21 976 | 25 188 |
EBITDA margin
-7.4%
This company
15.8%
Market median
-147% vs market
20152024
Equity ratio
53.1%
This company
38.2%
Market median
+39% vs market
20152024
Return on equity
-21.0%
This company
18.4%
Market median
-214% vs market
20152024
Net profit margin
-14.8%
This company
8.1%
Market median
-283% vs market
20152024
Asset turnover
0.75×
This company
1.12×
Market median
-33% vs market
20152024
Debt / equity
0.88×
This company
0.62×
Market median
+42% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LD Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
HT Audit | Audit | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
NovAx AB | Company | 52.0% | 52.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Axel Johnson Holding Aktiebolag
OneLab AB Board members of OneLab AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars David Strömbeck | Chief Executive Officer | 0 companies |
| Hans Thomas Kullman | Audit | 0 companies |
| Niclas Carl Jacob Palmstierna | Board of Directors | 0 companies |
| Åke Bertil Lundén | Board of Directors | 0 companies |
| Nils Markus Kullendorff | Board of Directors | 0 companies |
| Per Anders Rodebjer | Deputy Board Member | 0 companies |
| Carl Erik Björkegren | Board of Directors | 0 companies |
| Per Nils Åkerberg | Chairman | 0 companies |
| Josef Peter Bexell | Board of Directors | 0 companies |
| John Olof Ericsson | Board of Directors | 0 companies |